ATAI
Price
$2.45
Change
-$0.03 (-1.21%)
Updated
Jun 6, 01:21 PM (EDT)
Capitalization
494.83M
73 days until earnings call
RXRX
Price
$5.00
Change
+$0.44 (+9.63%)
Updated
Jun 6, 11:14 AM (EDT)
Capitalization
1.85B
67 days until earnings call
Interact to see
Advertisement

ATAI vs RXRX

Header iconATAI vs RXRX Comparison
Open Charts ATAI vs RXRXBanner chart's image
ATAI Life Sciences
Price$2.45
Change-$0.03 (-1.21%)
Volume$4K
Capitalization494.83M
Recursion Pharmaceuticals
Price$5.00
Change+$0.44 (+9.63%)
Volume$101.38K
Capitalization1.85B
ATAI vs RXRX Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. RXRX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ATAI: $2.48 vs. RXRX: $4.56)
Brand notoriety: ATAI and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 100% vs. RXRX: 146%
Market capitalization -- ATAI: $494.83M vs. RXRX: $1.85B
ATAI [@Biotechnology] is valued at $494.83M. RXRX’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 7 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • ATAI’s TA Score: 7 bullish, 3 bearish.
  • RXRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than RXRX.

Price Growth

ATAI (@Biotechnology) experienced а +6.90% price change this week, while RXRX (@Biotechnology) price change was +2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.11%, and the average quarterly price growth was +3.22%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.85B) has a higher market cap than ATAI($495M). ATAI YTD gains are higher at: 86.466 vs. RXRX (-32.544). ATAI has higher annual earnings (EBITDA): -124.33M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. ATAI (85.9M). ATAI has less debt than RXRX: ATAI (23.8M) vs RXRX (92.9M). RXRX has higher revenues than ATAI: RXRX (59.8M) vs ATAI (331K).
ATAIRXRXATAI / RXRX
Capitalization495M1.85B27%
EBITDA-124.33M-524.77M24%
Gain YTD86.466-32.544-266%
P/E RatioN/AN/A-
Revenue331K59.8M1%
Total Cash85.9M500M17%
Total Debt23.8M92.9M26%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
78

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAIRXRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIAGX17.19N/A
N/A
Brown Advisory Growth Equity Inv
CBBIX6.48N/A
N/A
AB Relative Value I
RMBKX45.78N/A
N/A
RMB Mendon Financial Services A
MSJCX16.53N/A
N/A
Morgan Stanley Global Endurance C
CSRIX49.35-0.01
-0.02%
Cohen & Steers Instl Realty Shares

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-7.13%
CRSP - RXRX
72%
Closely correlated
+1.37%
BEAM - RXRX
63%
Loosely correlated
-0.87%
ABCL - RXRX
60%
Loosely correlated
-2.27%
ABSI - RXRX
60%
Loosely correlated
-0.35%
NTLA - RXRX
57%
Loosely correlated
-1.30%
More